{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:48:25Z","timestamp":1791424105831,"version":"4.3.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11095-025-03891-7","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T17:37:14Z","timestamp":1753292234000},"page":"1409-1427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Influence of Milling Parameters on Crystal Morphology, Thermal Behavior, and Dissolution of Mesalamine Nanocrystals"],"prefix":"10.1007","volume":"42","author":[{"given":"Sakshi","family":"Kunjir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajakta","family":"Pathare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Deoriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramanian","family":"Natesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1435-6115","authenticated-orcid":false,"given":"Rajkumar","family":"Malayandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"3891_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jconrel.2005.11.013","volume":"111","author":"J Jinno","year":"2006","unstructured":"Jinno J, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M, et al. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J Control Release. 2006;111:56\u201364. https:\/\/doi.org\/10.1016\/j.jconrel.2005.11.013.","journal-title":"J Control Release"},{"key":"3891_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ejps.2019.04.003","volume":"134","author":"M Koziolek","year":"2019","unstructured":"Koziolek M, Alcaro S, Augustijns P, Basit AW, Grimm M, Hens B, et al. The mechanisms of pharmacokinetic food-drug interactions \u2013 A perspective from the UNGAP group. Eur J Pharm Sci. 2019;134:31\u201359. https:\/\/doi.org\/10.1016\/j.ejps.2019.04.003.","journal-title":"Eur J Pharm Sci"},{"key":"3891_CR3","doi-asserted-by":"publisher","unstructured":"Seibert KD, Collins PC, Luciani C V., Fisher ES. MILLING OPERATIONS IN THE PHARMACEUTICAL INDUSTRY. Chemical Engineering in the Pharmaceutical Industry, Wiley; 2019, p. 861\u201379. https:\/\/doi.org\/10.1002\/9781119600800.ch38.","DOI":"10.1002\/9781119600800.ch38"},{"key":"3891_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/2231-4040.82950","volume":"2","author":"V Patel","year":"2011","unstructured":"Patel V, Agrawal Y. Nanosuspension: An approach to enhance solubility of drugs. J Adv Pharm Technol Res. 2011;2:81. https:\/\/doi.org\/10.4103\/2231-4040.82950.","journal-title":"J Adv Pharm Technol Res"},{"key":"3891_CR5","doi-asserted-by":"publisher","first-page":"102040","DOI":"10.1016\/j.jddst.2020.102040","volume":"60","author":"D Jain","year":"2020","unstructured":"Jain D, Thakur PS, Thakore SD, Samal SK, Bansal AK. Impact of differential particle size of fenofibrate nanosuspensions on biopharmaceutical performance using physiologically based absorption modeling in rats. J Drug Deliv Sci Technol. 2020;60:102040. https:\/\/doi.org\/10.1016\/j.jddst.2020.102040.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3891_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3109\/10837450.2013.800107","volume":"19","author":"AA Abdelbary","year":"2014","unstructured":"Abdelbary AA, Li X, El-Nabarawi M, Elassasy A, Jasti B. Comparison of nanomilling and coprecipitation on the enhancement of in vitro dissolution rate of poorly water-soluble model drug aripiprazole. Pharm Dev Technol. 2014;19:491\u2013500. https:\/\/doi.org\/10.3109\/10837450.2013.800107.","journal-title":"Pharm Dev Technol"},{"key":"3891_CR7","doi-asserted-by":"publisher","first-page":"120370","DOI":"10.1016\/j.powtec.2024.120370","volume":"449","author":"AG Matveeva","year":"2025","unstructured":"Matveeva AG, Skripkina TS, Nekrasov VM, Nikiforova UE, Bukhtoyarov VA, Bychkov A, et al. Particle aggregation and the grinding limit in high energy ball mill. Powder Technol. 2025;449:120370. https:\/\/doi.org\/10.1016\/j.powtec.2024.120370.","journal-title":"Powder Technol"},{"key":"3891_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0032-5910(81)87015-5","volume":"28","author":"I Krycer","year":"1981","unstructured":"Krycer I, Hersey JA. Grinding and granulation in a vibratory ball mill. Powder Technol. 1981;28:91\u20135. https:\/\/doi.org\/10.1016\/0032-5910(81)87015-5.","journal-title":"Powder Technol"},{"key":"3891_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jiec.2025.01.054","volume":"149","author":"WA Ali","year":"2025","unstructured":"Ali WA, Richards SE, Alzard RH. Unlocking the potential of ball milling for nanomaterial Synthesis: An overview. J Ind Eng Chem. 2025;149:63\u201393. https:\/\/doi.org\/10.1016\/j.jiec.2025.01.054.","journal-title":"J Ind Eng Chem"},{"key":"3891_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ijpharm.2012.09.034","volume":"453","author":"JP M\u00f6schwitzer","year":"2013","unstructured":"M\u00f6schwitzer JP. Drug nanocrystals in the commercial pharmaceutical development process. Int J Pharm. 2013;453:142\u201356. https:\/\/doi.org\/10.1016\/j.ijpharm.2012.09.034.","journal-title":"Int J Pharm"},{"key":"3891_CR11","doi-asserted-by":"publisher","first-page":"102334","DOI":"10.1016\/j.apmt.2024.102334","volume":"40","author":"PS Chary","year":"2024","unstructured":"Chary PS, Shaikh S, Bhavana V, Rajana N, Vasave R, Mehra NK. Emerging role of nanocrystals in pharmaceutical applications: A review of regulatory aspects and drug development process. Appl Mater Today. 2024;40:102334. https:\/\/doi.org\/10.1016\/j.apmt.2024.102334.","journal-title":"Appl Mater Today"},{"key":"3891_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ajps.2014.12.006","volume":"10","author":"ZH Loh","year":"2015","unstructured":"Loh ZH, Samanta AK, Sia Heng PW. Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian J Pharm Sci. 2015;10:255\u201374. https:\/\/doi.org\/10.1016\/j.ajps.2014.12.006.","journal-title":"Asian J Pharm Sci"},{"key":"3891_CR13","doi-asserted-by":"publisher","first-page":"105222","DOI":"10.1016\/j.jddst.2023.105222","volume":"91","author":"PA Mura","year":"2024","unstructured":"Mura PA, Cirri M, Rossetti A, Allemandi DA, Paredes AJ, Palma SD. Preparation of glyburide nanocrystals with improved dissolution properties by dry-ball- and wet-bead- milling: Systematic comparison by experimental design of the performance of the two methods. J Drug Deliv Sci Technol. 2024;91:105222. https:\/\/doi.org\/10.1016\/j.jddst.2023.105222.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3891_CR14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3390\/pharmaceutics15020630","volume":"15","author":"MF Mu\u00f1oz Tecocoatzi","year":"2023","unstructured":"Mu\u00f1oz Tecocoatzi MF, P\u00e1ez-Franco JC, Rubio-Carrasco K, N\u00fa\u00f1ez-Pineda A, Dorazco-Gonz\u00e1lez A, Fuentes-Noriega I, et al. Ball-Milling Preparation of the Drug-Drug Solid Form of Pioglitazone-Rosuvastatin at Different Molar Ratios: Characterization and Intrinsic Dissolution Rates Evaluation. Pharm. 2023;15:630. https:\/\/doi.org\/10.3390\/pharmaceutics15020630.","journal-title":"Pharm"},{"key":"3891_CR15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/J.POWTEC.2018.02.022","volume":"330","author":"D Kumar","year":"2018","unstructured":"Kumar D, Worku ZA, Gao Y, Kamaraju VK, Glennon B, Babu RP, et al. Comparison of wet milling and dry milling routes for ibuprofen pharmaceutical crystals and their impact on pharmaceutical and biopharmaceutical properties. Powder Technol. 2018;330:228\u201338. https:\/\/doi.org\/10.1016\/J.POWTEC.2018.02.022.","journal-title":"Powder Technol"},{"key":"3891_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.apt.2010.03.015","volume":"22","author":"N Kotake","year":"2011","unstructured":"Kotake N, Kuboki M, Kiya S, Kanda Y. Influence of dry and wet grinding conditions on fineness and shape of particle size distribution of product in a ball mill. Adv Powder Technol. 2011;22:86\u201392. https:\/\/doi.org\/10.1016\/j.apt.2010.03.015.","journal-title":"Adv Powder Technol"},{"key":"3891_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2174\/2211738507666190405182524","volume":"7","author":"K Joshi","year":"2019","unstructured":"Joshi K, Chandra A, Jain K, Talegaonkar S. Nanocrystalization: An Emerging Technology to Enhance the Bioavailability of Poorly Soluble Drugs. Pharm Nanotechnol. 2019;7:259\u201378. https:\/\/doi.org\/10.2174\/2211738507666190405182524.","journal-title":"Pharm Nanotechnol"},{"key":"3891_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/10837450.2024.2334754","volume":"29","author":"D Memarvar","year":"2024","unstructured":"Memarvar D, Yaqoubi S, Hamishehkar H, Lam M, Nokhodchi A. Impact of grinding balls on the size reduction of Aprepitant in wet ball milling procedure. Pharm Dev Technol. 2024;29:353\u20138. https:\/\/doi.org\/10.1080\/10837450.2024.2334754.","journal-title":"Pharm Dev Technol"},{"key":"3891_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/pharmaceutics10030104","volume":"10","author":"L Peltonen","year":"2018","unstructured":"Peltonen L. Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques. Pharmaceutics. 2018;10:104. https:\/\/doi.org\/10.3390\/pharmaceutics10030104.","journal-title":"Pharmaceutics"},{"key":"3891_CR20","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1023\/A:1018909527659","volume":"10","author":"DL French","year":"1993","unstructured":"French DL, Mauger JW. Evaluation of the Physicochemical Properties and Dissolution Characteristics of Mesalamine: Relevance to Controlled Intestinal Drug Delivery. Pharm Res. 1993;10:1285\u201390. https:\/\/doi.org\/10.1023\/A:1018909527659.","journal-title":"Pharm Res"},{"key":"3891_CR21","doi-asserted-by":"crossref","unstructured":"Harris A, Patel M, Shah SA. Pharmacotherapy of Ulcerative Colitis: What Role for Mesalamine? 2010;2.","DOI":"10.4137\/CMRT.S1618"},{"key":"3891_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s13346-013-0185-4","volume":"4","author":"R Malayandi","year":"2014","unstructured":"Malayandi R, Kondamudi PK, Ruby PK, Aggarwal D. Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease. Drug Deliv Transl Res. 2014;4:187\u2013202. https:\/\/doi.org\/10.1007\/s13346-013-0185-4.","journal-title":"Drug Deliv Transl Res"},{"key":"3891_CR23","doi-asserted-by":"publisher","first-page":"500","DOI":"10.2165\/00003495-198938040-00003","volume":"38","author":"RN Brogden","year":"1989","unstructured":"Brogden RN, Sorkin EM. Mesalazine A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Chronic Inflammatory Bowel Disease. Drugs. 1989;38:500\u201323. https:\/\/doi.org\/10.2165\/00003495-198938040-00003.","journal-title":"Drugs"},{"key":"3891_CR24","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1517\/17425247.2011.606808","volume":"8","author":"A Singh","year":"2011","unstructured":"Singh A, Worku ZA, Van den Mooter G. Oral formulation strategies to improve solubility of poorly water-soluble drugs. Expert Opin Drug Deliv. 2011;8:1361\u201378. https:\/\/doi.org\/10.1517\/17425247.2011.606808.","journal-title":"Expert Opin Drug Deliv"},{"key":"3891_CR25","doi-asserted-by":"publisher","first-page":"120301","DOI":"10.1016\/j.lfs.2022.120301","volume":"291","author":"KU Khan","year":"2022","unstructured":"Khan KU, Minhas MU, Badshah SF, Suhail M, Ahmad A, Ijaz S. Overview of nanoparticulate strategies for solubility enhancement of poorly soluble drugs. Life Sci. 2022;291:120301. https:\/\/doi.org\/10.1016\/j.lfs.2022.120301.","journal-title":"Life Sci"},{"key":"3891_CR26","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/pharmaceutics10030134","volume":"10","author":"MR Gigliobianco","year":"2018","unstructured":"Gigliobianco MR, Casadidio C, Censi R, Di Martino P. Nanocrystals of Poorly Soluble Drugs: Drug Bioavailability and Physicochemical Stability. Pharmaceutics. 2018;10:134. https:\/\/doi.org\/10.3390\/pharmaceutics10030134.","journal-title":"Pharmaceutics"},{"key":"3891_CR27","doi-asserted-by":"publisher","unstructured":"Ghurghure SM, Vhankade H. EPRA International Journal of Research and Development (IJRD) Solubility Enhancement of Mesalamine by Nanocrystal Technique. n.d. https:\/\/doi.org\/10.36713\/epra2016.","DOI":"10.36713\/epra2016"},{"key":"3891_CR28","doi-asserted-by":"publisher","unstructured":"Kulkarni SA, Myerson AS. Methods for Nano-Crystals Preparation; 2017. p. 275\u201387. https:\/\/doi.org\/10.1007\/978-94-024-1117-1_16.","DOI":"10.1007\/978-94-024-1117-1_16"},{"key":"3891_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijpharm.2019.02.045","volume":"562","author":"IS Mohammad","year":"2019","unstructured":"Mohammad IS, Hu H, Yin L, He W. Drug nanocrystals: Fabrication methods and promising therapeutic applications. Int J Pharm. 2019;562:187\u2013202. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.02.045.","journal-title":"Int J Pharm"},{"key":"3891_CR30","doi-asserted-by":"publisher","unstructured":"Shegokar R. Wet Media Milling: An Effective Way to Solve Drug Solubility Issue. Handbook of Nanoparticles, Cham: Springer International Publishing; 2016. p. 385\u2013406. https:\/\/doi.org\/10.1007\/978-3-319-15338-4_20.","DOI":"10.1007\/978-3-319-15338-4_20"},{"key":"3891_CR31","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.addr.2011.02.001","volume":"63","author":"L Wu","year":"2011","unstructured":"Wu L, Zhang J, Watanabe W. Physical and chemical stability of drug nanoparticles. Adv Drug Deliv Rev. 2011;63:456\u201369. https:\/\/doi.org\/10.1016\/j.addr.2011.02.001.","journal-title":"Adv Drug Deliv Rev"},{"key":"3891_CR32","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.drudis.2018.01.016","volume":"23","author":"M Malamatari","year":"2018","unstructured":"Malamatari M, Taylor KMG, Malamataris S, Douroumis D, Kachrimanis K. Pharmaceutical nanocrystals: production by wet milling and applications. Drug Discov Today. 2018;23:534\u201347. https:\/\/doi.org\/10.1016\/j.drudis.2018.01.016.","journal-title":"Drug Discov Today"},{"key":"3891_CR33","unstructured":"Soluplus \u00ae Polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer for pharmaceutical use. n.d."},{"key":"3891_CR34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.colsurfb.2014.07.037","volume":"122","author":"A Homayouni","year":"2014","unstructured":"Homayouni A, Sadeghi F, Varshosaz J, Afrasiabi Garekani H, Nokhodchi A. Promising dissolution enhancement effect of soluplus on crystallized celecoxib obtained through antisolvent precipitation and high pressure homogenization techniques. Colloids Surf B Biointerfaces. 2014;122:591\u2013600. https:\/\/doi.org\/10.1016\/j.colsurfb.2014.07.037.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"3891_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0378-5173(90)90132-N","volume":"63","author":"H Marques","year":"1990","unstructured":"Marques H, Hadgraft J, Kellaway I. Studies of cyclodextrin inclusion complexes. I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC. Int J Pharm. 1990;63:259\u201366. https:\/\/doi.org\/10.1016\/0378-5173(90)90132-N.","journal-title":"Int J Pharm"},{"key":"3891_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.12691\/ajbr-1-3-3","volume":"1","author":"S Chhater","year":"2013","unstructured":"Chhater S, Praveen K. Solid Dispersion Incorporated Microcapsules: Predictive Tools for Improve the Half Life and Dissolution Rate of Pioglitazone Hydrochloride. Am J Biomed Res. 2013;1:57\u201370. https:\/\/doi.org\/10.12691\/ajbr-1-3-3.","journal-title":"Am J Biomed Res"},{"key":"3891_CR37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jpba.2007.10.030","volume":"46","author":"E Baka","year":"2008","unstructured":"Baka E, Comer JEA, Tak\u00e1cs-Nov\u00e1k K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal. 2008;46:335\u201341. https:\/\/doi.org\/10.1016\/j.jpba.2007.10.030.","journal-title":"J Pharm Biomed Anal"},{"key":"3891_CR38","doi-asserted-by":"publisher","first-page":"116300","DOI":"10.1016\/j.molliq.2021.116300","volume":"336","author":"A Zarghampour","year":"2021","unstructured":"Zarghampour A, Moradi M, Martinez F, Hemmati S, Rahimpour E, Jouyban A. Solubility study of mesalazine in the aqueous mixtures of a deep-eutectic solvent at different temperatures. J Mol Liq. 2021;336:116300. https:\/\/doi.org\/10.1016\/j.molliq.2021.116300.","journal-title":"J Mol Liq"},{"key":"3891_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.18553\/jmcp.2009.15.3.253","volume":"15","author":"S Hill","year":"2009","unstructured":"Hill S, Varker AS, Karlage K, Myrdal PB. Analysis of Drug Content and Weight Uniformity for Half-Tablets of 6 Commonly Split Medications. J Manag Care Pharm. 2009;15:253\u201361. https:\/\/doi.org\/10.18553\/jmcp.2009.15.3.253.","journal-title":"J Manag Care Pharm"},{"key":"3891_CR40","doi-asserted-by":"publisher","first-page":"13321","DOI":"10.1007\/s10973-023-12639-7","volume":"148","author":"R Malayandi","year":"2023","unstructured":"Malayandi R, Malgave A, Gaikwad V, Peraman R, Aishwarya D, Ravichandiran V. Understanding the influence of thermal cycles on the stability of metformin HCl in presence of Sitagliptin phosphate monohydrate and polyvinyl alcohol. J Therm Anal Calorim. 2023;148:13321\u201335. https:\/\/doi.org\/10.1007\/s10973-023-12639-7.","journal-title":"J Therm Anal Calorim"},{"key":"3891_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.fjps.2017.07.001","volume":"4","author":"S Sen","year":"2018","unstructured":"Sen S, Das M, Ghosh B, Ghosh LK. Design, development and in vitro evaluation of sequentially optimized mesalamine tablets for optimum colonic delivery. Futur J Pharm Sci. 2018;4:8\u201313. https:\/\/doi.org\/10.1016\/j.fjps.2017.07.001.","journal-title":"Futur J Pharm Sci"},{"key":"3891_CR42","doi-asserted-by":"publisher","first-page":"213735","DOI":"10.1016\/j.bioadv.2023.213735","volume":"157","author":"ME Rabeh","year":"2024","unstructured":"Rabeh ME, Vora LK, Moore JV, Bayan MF, McCoy CP, Wylie MP. Dual stimuli-responsive delivery system for self-regulated colon-targeted delivery of poorly water-soluble drugs. Biomater Adv. 2024;157:213735. https:\/\/doi.org\/10.1016\/j.bioadv.2023.213735.","journal-title":"Biomater Adv"},{"key":"3891_CR43","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ijpharm.2014.05.052","volume":"472","author":"D Leng","year":"2014","unstructured":"Leng D, Chen H, Li G, Guo M, Zhu Z, Xu L, et al. Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size. Int J Pharm. 2014;472:380\u20135. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.05.052.","journal-title":"Int J Pharm"},{"key":"3891_CR44","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jfda.2017.07.004","volume":"26","author":"P-J Lu","year":"2018","unstructured":"Lu P-J, Fu W-E, Huang S-C, Lin C-Y, Ho M-L, Chen Y-P, et al. Methodology for sample preparation and size measurement of commercial ZnO nanoparticles. J Food Drug Anal. 2018;26:628\u201336. https:\/\/doi.org\/10.1016\/j.jfda.2017.07.004.","journal-title":"J Food Drug Anal"},{"key":"3891_CR45","doi-asserted-by":"publisher","first-page":"105580","DOI":"10.1016\/j.jddst.2024.105580","volume":"95","author":"ND Alshammari","year":"2024","unstructured":"Alshammari ND, Almotairy A, Almutairi M, Zhang P, Al Shawakri E, Vemula SK, et al. Colon-targeted 3D-Printed mesalamine tablets: Core-shell design and in vitro\/ex-vivo evaluation. J Drug Deliv Sci Technol. 2024;95:105580. https:\/\/doi.org\/10.1016\/j.jddst.2024.105580.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3891_CR46","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s11694-023-02167-1","volume":"18","author":"H Sakr","year":"2024","unstructured":"Sakr H, Ammar A, Zaki H, Salama MA, Ali M. Impact of ball milling on physicochemical, structural, and functional properties of Moringa oleifera L. leaf powders. J Food Mea Charact. 2024;18:320\u201330. https:\/\/doi.org\/10.1007\/s11694-023-02167-1.","journal-title":"J Food Mea Charact"},{"key":"3891_CR47","doi-asserted-by":"publisher","first-page":"124196","DOI":"10.1016\/j.ijpharm.2024.124196","volume":"658","author":"J Che","year":"2024","unstructured":"Che J, Fu Y, Li Y, Zhang Y, Yin T, Gou J, et al. Eudragit L100-coated nintedanib nanocrystals improve oral bioavailability by reducing drug particle size and maintaining drug supersaturation. Int J Pharm. 2024;658:124196. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.124196.","journal-title":"Int J Pharm"},{"key":"3891_CR48","doi-asserted-by":"publisher","first-page":"105844","DOI":"10.1016\/j.jddst.2024.105844","volume":"98","author":"HM Fadda","year":"2024","unstructured":"Fadda HM. Effect of postprandial gastric conditions on in vitro drug release from modified release mesalamine formulations. J Drug Deliv Sci Technol. 2024;98:105844. https:\/\/doi.org\/10.1016\/j.jddst.2024.105844.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3891_CR49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.powtec.2016.09.004","volume":"302","author":"OP Sharma","year":"2016","unstructured":"Sharma OP, Patel V, Mehta T. Design of experiment approach in development of febuxostat nanocrystal: Application of Soluplus\u00ae as stabilizer. Powder Technol. 2016;302:396\u2013405. https:\/\/doi.org\/10.1016\/j.powtec.2016.09.004.","journal-title":"Powder Technol"},{"key":"3891_CR50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jddst.2017.09.011","volume":"43","author":"KD Koradia","year":"2018","unstructured":"Koradia KD, Sheth NR, Koradia HD, Dabhi MR. Ziprasidone nanocrystals by wet media milling followed by spray drying and lyophilization: Formulation and process parameter optimization. J Drug Deliv Sci Technol. 2018;43:73\u201384. https:\/\/doi.org\/10.1016\/j.jddst.2017.09.011.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3891_CR51","doi-asserted-by":"publisher","first-page":"16352","DOI":"10.1038\/srep16352","volume":"5","author":"JS Koner","year":"2015","unstructured":"Koner JS, Rajabi-Siahboomi A, Bowen J, Perrie Y, Kirby D, Mohammed AR. A Holistic Multi Evidence Approach to Study the Fragmentation Behaviour of Crystalline Mannitol. Sci Rep. 2015;5:16352. https:\/\/doi.org\/10.1038\/srep16352.","journal-title":"Sci Rep"},{"key":"3891_CR52","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1021\/mp100198q","volume":"7","author":"HM Fadda","year":"2010","unstructured":"Fadda HM, Sousa T, Carlsson AS, Abrahamsson B, Williams JG, Kumar D, et al. Drug solubility in luminal fluids from different regions of the small and large intestine of humans. Mol Pharm. 2010;7:1527\u201332. https:\/\/doi.org\/10.1021\/mp100198q.","journal-title":"Mol Pharm"},{"key":"3891_CR53","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40268-015-0097-5","volume":"15","author":"S Tenjarla","year":"2015","unstructured":"Tenjarla S. Dissolution of commercially available mesalamine formulations at various pH levels. Drugs in R and D. 2015;15:211\u20135. https:\/\/doi.org\/10.1007\/s40268-015-0097-5.","journal-title":"Drugs in R and D"},{"key":"3891_CR54","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.powtec.2014.01.095","volume":"257","author":"DR Ely","year":"2014","unstructured":"Ely DR, Edwin Garc\u00eda R, Thommes M. Ostwald-Freundlich diffusion-limited dissolution kinetics of nanoparticles. Powder Technol. 2014;257:120\u20133. https:\/\/doi.org\/10.1016\/j.powtec.2014.01.095.","journal-title":"Powder Technol"},{"key":"3891_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1155\/2011\/382137","volume":"8","author":"TR Kanubhai","year":"2011","unstructured":"Kanubhai TR, Mukesh CP, Amit RK. Determination of Mesalamine Related Impurities from Drug Product by Reversed Phase Validated UPLC Method. J Chem. 2011;8:131\u201348. https:\/\/doi.org\/10.1155\/2011\/382137.","journal-title":"J Chem"},{"key":"3891_CR56","doi-asserted-by":"publisher","first-page":"79661","DOI":"10.1039\/C5RA17309D","volume":"5","author":"P Pandey","year":"2015","unstructured":"Pandey P. Evidence of blue-shifting N-H\u22efN hydrogen bonding despite elongation of the N\u2013H bond. RSC Adv. 2015;5:79661\u20134. https:\/\/doi.org\/10.1039\/C5RA17309D.","journal-title":"RSC Adv"},{"key":"3891_CR57","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1208\/s12249-013-9931-7","volume":"14","author":"V Caron","year":"2013","unstructured":"Caron V, Hu Y, Tajber L, Erxleben A, Corrigan OI, McArdle P, et al. Amorphous Solid Dispersions of Sulfonamide\/Soluplus\u00ae and Sulfonamide\/PVP Prepared by Ball Milling. AAPS PharmSciTech. 2013;14:464\u201374. https:\/\/doi.org\/10.1208\/s12249-013-9931-7.","journal-title":"AAPS PharmSciTech"},{"key":"3891_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12668-024-01712-6","volume":"15","author":"S Kunjir","year":"2025","unstructured":"Kunjir S, Pathare P, Sharma S, Malayandi R, Malgave A, Natesan S. Development and Validation of Particle Size Measurement for Mesalamine Nanocrystals Using Dynamic Light Scattering and Microscopic Techniques. Bionanoscience. 2025;15:27. https:\/\/doi.org\/10.1007\/s12668-024-01712-6.","journal-title":"Bionanoscience"},{"key":"3891_CR59","doi-asserted-by":"publisher","first-page":"114646","DOI":"10.1016\/j.addr.2022.114646","volume":"192","author":"J Zhang","year":"2023","unstructured":"Zhang J, Khanal D, Banaszak Holl MM. Applications of AFM-IR for drug delivery vector characterization: infrared, thermal, and mechanical characterization at the nanoscale. Adv Drug Deliv Rev. 2023;192:114646. https:\/\/doi.org\/10.1016\/j.addr.2022.114646.","journal-title":"Adv Drug Deliv Rev"},{"key":"3891_CR60","doi-asserted-by":"publisher","first-page":"104519","DOI":"10.1016\/j.jddst.2023.104519","volume":"84","author":"MS Attia","year":"2023","unstructured":"Attia MS, Elshahat A, Hamdy A, Fathi AM, Emad-Eldin M, Ghazy F-ES, et al. Soluplus\u00ae as a solubilizing excipient for poorly water-soluble drugs: Recent advances in formulation strategies and pharmaceutical product features. J Drug Deliv Sci Technol. 2023;84:104519. https:\/\/doi.org\/10.1016\/j.jddst.2023.104519.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3891_CR61","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ijpharm.2013.07.021","volume":"455","author":"B Zuo","year":"2013","unstructured":"Zuo B, Sun Y, Li H, Liu X, Zhai Y, Sun J, et al. Preparation and in vitro\/in vivo evaluation of fenofibrate nanocrystals. Int J Pharm. 2013;455:267\u201375. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.07.021.","journal-title":"Int J Pharm"},{"key":"3891_CR62","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1021\/acs.oprd.6b00434","volume":"21","author":"N Pudasaini","year":"2017","unstructured":"Pudasaini N, Upadhyay PP, Parker CR, Hagen SU, Bond AD, Rantanen J. Downstream Processability of Crystal Habit-Modified Active Pharmaceutical Ingredient. Org Process Res Dev. 2017;21:571\u20137. https:\/\/doi.org\/10.1021\/acs.oprd.6b00434.","journal-title":"Org Process Res Dev"},{"key":"3891_CR63","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/ma10030272","volume":"10","author":"R Kumar","year":"2017","unstructured":"Kumar R, Bakshi S, Joardar J, Parida S, Raja V, Singh RR. Structural Evolution during Milling, Annealing, and Rapid Consolidation of Nanocrystalline Fe\u201310Cr\u20133Al Powder. Mater. 2017;10:272. https:\/\/doi.org\/10.3390\/ma10030272.","journal-title":"Mater"},{"key":"3891_CR64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejps.2005.08.013","volume":"27","author":"V Chikhalia","year":"2006","unstructured":"Chikhalia V, Forbes RT, Storey RA, Ticehurst M. The effect of crystal morphology and mill type on milling induced crystal disorder. Eur J Pharm Sci. 2006;27:19\u201326. https:\/\/doi.org\/10.1016\/j.ejps.2005.08.013.","journal-title":"Eur J Pharm Sci"},{"key":"3891_CR65","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/jps.20044","volume":"93","author":"R-M Dannenfelser","year":"2004","unstructured":"Dannenfelser R-M, He H, Joshi Y, Bateman S, Serajuddin ATM. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol\u2013polysorbate 80 solid dispersion carrier system. J Pharm Sci. 2004;93:1165\u201375. https:\/\/doi.org\/10.1002\/jps.20044.","journal-title":"J Pharm Sci"},{"key":"3891_CR66","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.ejpb.2013.03.002","volume":"85","author":"K Zhang","year":"2013","unstructured":"Zhang K, Yu H, Luo Q, Yang S, Lin X, Zhang Y, et al. Increased dissolution and oral absorption of itraconazole\/Soluplus extrudate compared with itraconazole nanosuspension. Eur J Pharm Biopharm. 2013;85:1285\u201392. https:\/\/doi.org\/10.1016\/j.ejpb.2013.03.002.","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03891-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-025-03891-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-025-03891-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T14:42:52Z","timestamp":1756824172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-025-03891-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3891"],"URL":"https:\/\/doi.org\/10.1007\/s11095-025-03891-7","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Yes). The authors declare the following financial interests\/personal relationships which may be considered as potential competing interests: (No).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}